Phase III Study of PSC-833 (Valspodar) in Combination with Vincristine, Doxorubicin, and Dexamethasone (Valspodar/VAD) versus VAD Alone in Patients with Recurring or Refractory Multiple Myeloma (E1A95)
Loading...
Date
2006
Authors
Friedenberg, William R.
Rué i Monné, Montserrat
Blood, Emily
Dalton, William S.
Shustik, Chaim
Larson, Richard A.
Sonneveld, Pieter
Greipp, Philip R.
Other authors
Impact
Export
Share
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
Cancer, 2006, vol. 106, núm. 4, p. 830-838